Chronic low-dose follicle-stimulating hormone compared with clomiphene/human menopausal gonadotropin for induction of ovulation.

Concurrent administration of clomiphene can reduce the amount of gonadotropins required for induction of ovulation. Recently, follicle-stimulating hormone (FSH) administered in a chronic, low-dose fashion has been reported to give satisfactory pregnancy rates. We compared the conventional clomiphene/human menopausal gonadotropin (hMG) with the chronic, low-dose FSH regimen for induction of ovulation in 87 patients over 110 cycles. The clomiphene/hMG regimen required half the amount of gonadotropin compared to the chronic FSH regimen to achieve follicular maturation. Despite the reduced amount of gonadotropin, the clomiphene/hMG regimen induced a mean fourfold higher level of estradiol production and was associated with significantly greater numbers of large and intermediate-sized follicles compared to the chronic FSH regimen. The proportion of clomiphene/hMG cases with multifollicular development and overstimulation was therefore high (30%). In contrast, the chronic FSH regimen, despite requiring larger amounts of gonadotropin and longer periods of treatment, resulted in unifollicular development, low rates of overstimulation and improved pregnancy rates. We conclude that although clomiphene can reduce the requirement for gonadotropins, the relative safety and effectiveness of the chronic low-dose FSH regimen makes it the method of choice for ovulation induction.

[1]  Z. Ben-Rafael,et al.  A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome. , 1995, Fertility and sterility.

[2]  M. Afnan,et al.  Ovarian response in consecutive cycles of ovarian stimulation in normally ovulating women. , 1995, Human reproduction.

[3]  Z. Ben-Rafael,et al.  The choice of treatment for anovulation associated with polycystic ovary syndrome following failure to conceive with clomiphene. , 1993, Human reproduction.

[4]  R. Frydman,et al.  Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment. , 1993, Fertility and sterility.

[5]  P. Tuppin,et al.  Trends in multiple deliveries and infertility treatments in France , 1993, British journal of obstetrics and gynaecology.

[6]  D. Irvine,et al.  The effect of three anti-oestrogen drugs on cervical mucus quality and in-vitro sperm-cervical mucus interaction in ovulatory women. , 1993, Human reproduction.

[7]  H. Bohnet,et al.  Morphometric characteristics of endometrial biopsies after different types of ovarian stimulation for infertility treatment. , 1993, Fertility and sterility.

[8]  M. Diver,et al.  The effect of clomiphene citrate treatment on cervical mucus and plasma estradiol and progesterone levels. , 1993, Fertility and sterility.

[9]  R. Dickey,et al.  Sequential clomiphene citrate and human menopausal gonadotrophin for ovulation induction: comparison to clomiphene citrate alone and human menopausal gonadotrophin alone. , 1993, Human reproduction.

[10]  R. Lobo,et al.  The synergistic effects of clomiphene citrate and human menopausal gonadotrophin in the folliculogenesis of stimulated cycles as assessed by the gonadotrophin-releasing hormone antagonist Nal-Glu. , 1992, Human reproduction.

[11]  Z. Shoham,et al.  Polycystic ovarian syndrome: safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone. , 1991, Fertility and sterility.

[12]  S. Franks,et al.  A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome. , 1991, Fertility and sterility.

[13]  L. Regan,et al.  Hypersecretion of luteinising hormone, infertility, and miscarriage , 1990, The Lancet.

[14]  J. Adams,et al.  Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. , 1988, BMJ.

[15]  M. Seibel,et al.  Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: biochemical changes and ultrasound correlation. , 1984, International journal of fertility.

[16]  M. Seibel,et al.  Reversal of persistent anovulation in polycystic ovarian disease by administration of chronic low-dose follicle-stimulating hormone. , 1982, Fertility and sterility.

[17]  R. Kistner,et al.  Sequential use of clomiphene citrate and human menopausal gonadotropin in ovulation induction. , 1976, Fertility and sterility.

[18]  J. E. Johnson,et al.  Further clinical experience with clomiphene citrate. , 1968, Fertility and sterility.

[19]  R. Kistner.  Use of Clomiphene Citrate, Human Chorionic Gonadotropin, and Human Menopausal Gonadotropin for Induction of Ovulation in the Human Female , 1966 .